Latest Regulatory Challenges News

Page 2 of 23
Codeifai Limited reported a 26% revenue decline to $598,497 for 2025 alongside a sharp increase in net loss to $6.22 million, driven by strategic investments and market challenges. The company’s pivot to self-service SaaS platforms, including a key acquisition post-year-end, signals a transformative but uncertain path forward.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Yowie Group Limited reported a steep 752% increase in its half-year loss to US$4.66 million, amid governance upheaval and impaired loans to its majority shareholder. The company faces ongoing legal and regulatory challenges while pursuing a turnaround.
Victor Sage
Victor Sage
27 Feb 2026
Coles Group reported a 2.5% revenue increase to $23.7 billion for the half year ended January 2026, driven by strong supermarket sales, but earnings were weighed down by a $235 million provision linked to a Fair Work Ombudsman ruling. The company declared a fully franked interim dividend of 41 cents per share.
Logan Eniac
Logan Eniac
27 Feb 2026
Careteq Limited reported a widening half-year loss with revenues down 18%, announcing plans to sell its Embedded Health Solutions business to strengthen its balance sheet and focus on its HMR Referral platform.
Ada Torres
Ada Torres
26 Feb 2026
Doctor Care Anywhere has reported its first profitable year, driven by a 6.5% revenue growth and improved margins, setting the stage for accelerated growth in 2026. The telehealth provider reaffirms ambitious medium-term targets amid operational enhancements and new clinical pathways.
Ada Torres
Ada Torres
25 Feb 2026
Sequoia Financial Group reported a 75.9% jump in operating profit for 1H FY26 despite a net loss after non-operating charges, prompting a cautious dividend cut amid regulatory challenges.
Claire Turing
Claire Turing
23 Feb 2026
Toubani Resources has obtained the crucial environmental permit for its Kobada Gold Project, clearing the way for construction and initiating resettlement activities as planned.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.
Ada Torres
Ada Torres
20 Feb 2026
Solvar Limited reported a 5.8% rise in net profit for the half year ending December 2025, driven by strategic asset sales and expanded funding facilities. The company declared both interim and special dividends, signalling confidence despite ongoing regulatory challenges.
Claire Turing
Claire Turing
18 Feb 2026
Smart Parking Limited reported a robust half-year result for December 2025, nearly doubling revenue to $62.6 million and boosting adjusted EBITDA by 85%, driven by its US acquisition and international growth.
Sophie Babbage
Sophie Babbage
17 Feb 2026
ADX Energy has reported encouraging initial flow test results from the Reifling Formation at its Welchau-1 well, confirming the presence of methane gas and potential light oil. Ongoing testing aims to establish sustained production and further reservoir characteristics.
Maxwell Dee
Maxwell Dee
16 Feb 2026
Fiducian Group’s FY2026 half-year results reveal robust growth with a 9% rise in funds under management and a 17% jump in underlying net profit, despite ongoing regulatory challenges.
Claire Turing
Claire Turing
16 Feb 2026